Compounds > (3S-5S-6E)-7-[3-(4-fluorophenyl)-1-(propan-2-yl)-1H-indol-2-yl]-3-5-dihydroxyhept-6-enoic-acid

(3S-5S-6E)-7-[3-(4-fluorophenyl)-1-(propan-2-yl)-1H-indol-2-yl]-3-5-dihydroxyhept-6-enoic-acid and Respiratory-Distress-Syndrome

(3S-5S-6E)-7-[3-(4-fluorophenyl)-1-(propan-2-yl)-1H-indol-2-yl]-3-5-dihydroxyhept-6-enoic-acid has been researched along with Respiratory-Distress-Syndrome* in 1 studies

Other Studies

1 other study(ies) available for (3S-5S-6E)-7-[3-(4-fluorophenyl)-1-(propan-2-yl)-1H-indol-2-yl]-3-5-dihydroxyhept-6-enoic-acid and Respiratory-Distress-Syndrome

ArticleYear
Fatal lupus-like syndrome and ARDS induced by fluvastatin.
    Lancet (London, England), 1998, Jul-11, Volume: 352, Issue:9122

    Topics: Aged; Anticholesteremic Agents; Fatal Outcome; Fatty Acids, Monounsaturated; Female; Fluvastatin; Humans; Indoles; Lupus Erythematosus, Systemic; Respiratory Distress Syndrome

1998